학술논문
Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
Document Type
Academic Journal
Author
Source
The New England Journal of Medicine. Sept 5, 1996, Vol. v335 Issue n10, p696, 5 p.
Subject
Language
ISSN
0028-4793
Abstract
Enoxaparin may be effective in lowering the incidence of thromboembolism after hip replacement surgery. Thromboembolism occurs when a blood clot forms, travels through the bloodstream and cuts off the blood supply to an organ. A total of 262 patients receiving an artificial hip joint were given enoxaparin during their hospitalization and then were randomly allocated to continue the drug or a placebo for one month. At the end of the study, only 18% of those on enoxaparin developed thromboembolism, compared to 39% of those on placebo. Enoxaparin is low-molecular-weight heparin.